ARTICLE | Company News
Genentech, ImmunoGen other research news
November 5, 2001 8:00 AM UTC
DNA and IMGN reported that treatment with Trastuzumab-DM1 caused complete tumor regression in a Herceptin-sensitive mouse xenograft tumor model and >90% tumor regression in a Herceptin-resistant mouse...